Forbion — 2012 Investments
1 investments dated 2012 · listed companies and verified rows first · show all
Promediorpromedior.comFeb 2012
BiotechMalvern, US
Mark Lupher(Executive Officer)James W. Broderick, M.D.(Director)Dominick C. Colangelo(Executive Officer, Director)Paul D. Goldenheim, M.D.(Director)Harold R. Werner(Director)Amir Nashat(Director)
Co-investorsEaston CapitalSofinnova VenturesEaston Capital Investment Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.